About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Sexual Function Changes in High-Risk Pregnancies | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT05093647

Sexual Function Changes in High-Risk Pregnancies

Sexual Function Changes in High-Risk Pregnancies

Lead sponsor: Saglik Bilimleri Universitesi•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Saglik Bilimleri Universitesi

Background and Aim: Sexual functions generally decrease during pregnancy, and high-risk pregnancies are more severe clinical conditions that cause couples to reduce or abstain entirely from their intimacy. However, the evidence on the sexual functions in high-risk pregnancies is scarce. Therefore, this study aimed to evaluate the sexual function changes in high-risk pregnancies compared to normal pregnancies. Methods: A total of 200 pregnant women (100 women in high-risk pregnancy and normal pregnancy groups each) were included. Demographic and obstetric data were collected, and participants completed The Female Sexual Function Index (FSFI).

Age

20 - 40 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•study grup Pregnant women who ; followed up for HrP in the second trimester (14th to 28th gestational weeks), between 20 to 40 years old, followed up at our perinatology department with a diagnosis of IUGR, cholestasis, diabetes, preeclampsia, fetal anomaly control grup admitted for routine second-trimester ultrasonography assessment but with no risk for pregnancy

Exclusion Criteria

•Pregnant women who ; younger than 20 or older than 40 years of age, gestation in the 1st or 3rd trimester, presence of psychiatric or chronic disorders like rheumatic or heart diseases,
•\-

Related studies

Rigorous Evaluation of Let's Talk Birth Control

NCT06670066 · Sexual Behavior, Adolescent Behavior

Treatment for Problematic Sexual Behavior of Preteen Children

NCT05514730 · Problematic Sexual Behavior Among Preteen Children

Early Psychological Intervention After Rape

NCT05489133 · Post Traumatic Stress Disorder, Rape Sexual Assault, and more

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage

NCT06655207 · Post Partum Haemorrhage, Maternal Care Patterns, and more

Effectiveness of ACT for Problematic Chemsex

NCT06406296 · Hypersexuality, Compulsive Sexual Behavior, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 11, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment200

Start dateApr 2021

Last updatedMay 11, 2022

Condition

Sexual Dysfunctions, Psychological High Risk Pregnancy Sexual Behavior

Locations shown

Department of Obstetrics and Gynecology, Maternal-Fetal Medicine Unit, Başakşehir City Hospital, Hamidiye School of Medicine, University of Health Sciences,

Başaksehir, Istanbul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 11, 2022Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions